PT - JOURNAL ARTICLE AU - Andrew J. Peacock AU - Anton Vonk Noordegraaf TI - Cardiac magnetic resonance imaging in pulmonary arterial hypertension AID - 10.1183/09059180.00006313 DP - 2013 Dec 01 TA - European Respiratory Review PG - 526--534 VI - 22 IP - 130 4099 - http://err.ersjournals.com/content/22/130/526.short 4100 - http://err.ersjournals.com/content/22/130/526.full SO - EUROPEAN RESPIRATORY REVIEW2013 Dec 01; 22 AB - Cardiac magnetic resonance imaging (CMRI) provides accurate information about right ventricular (RV) mass, RV volumes and other markers of RV function. CMRI is proving to be a particularly useful tool in pulmonary arterial hypertension (PAH), as measures of RV function have been shown to be prognostic of long-term outcomes in this disease. Changes in RV function can also provide important information about a patient's disease course and response to treatment. As CMRI is noninvasive it can be used to regularly monitor patients with PAH, which is an important advantage over invasive right heart catheterisation. This review will explore the use of CMRI in the context of existing monitoring tools for PAH and will explore the forthcoming developments that are likely to be important in the future monitoring of patients with PAH.